|
13 Jul 2025 |
IndusInd Bank
|
Consensus Share Price Target
|
858.85 |
801.00 |
- |
-6.74 |
sell
|
|
|
|
|
22 May 2025
|
IndusInd Bank
|
IDBI Capital
|
858.85
|
680.00
|
785.00
(9.41%)
|
20.82 |
Sell
|
|
|
|
|
22 May 2025
|
IndusInd Bank
|
Prabhudas Lilladhar
|
858.85
|
780.00
|
785.00
(9.41%)
|
Target met |
Hold
|
|
|
IIB saw an abnormal but weak quarter as it reported a net loss of Rs22.4bn due to recognition of accounting lapses. While forex loss of Rs19.6bn and interest reversal on MFI loans Rs5.7bn were expected, increased MFI stress of Rs19.7bn led to QoQ spike of 81bps in provisions to 281bps; contingent provisions of Rs13.25bn were fully utilized. Our sense is that most of the lapses have been corrected, and no significant deviations are expected. For FY26/27E we trim loan growth by 5%/2% to 8%/11% and subsequently due to cascading effect...
|
|
22 May 2025
|
IndusInd Bank
|
BP Wealth
|
858.85
|
|
785.00
(9.41%)
|
|
Results Update
|
|
|
|
|
22 May 2025
|
IndusInd Bank
|
ICICI Securities Limited
|
858.85
|
650.00
|
785.00
(9.41%)
|
24.32 |
Sell
|
|
|
IndusInd Bank (IIB) reported higher-than-expected Q4FY25 loss of INR 22.4bn (RoA of -1.74%) burdened by multiple oneoffs, including derivative loss and irregularities in its MFI book while slippages/net NPA jumped QoQ.
|
|
21 May 2025
|
IndusInd Bank
|
Motilal Oswal
|
858.85
|
650.00
|
769.95
(11.55%)
|
-24.32 |
Neutral
|
|
|
IndusInd Bank (IIB) reported a loss of INR23.3b (vs our est. of INR1.4b loss), led by muted NII (interest reversal of INR6.7b and higherslippages) and tepid other income amid the reversal of derivative loss of INR19.6b.
|
|
30 Apr 2025
|
IndusInd Bank
|
Emkay
|
858.85
|
725.00
|
838.40
(2.44%)
|
15.58 |
Sell
|
|
|
We downgrade IIB to REDUCE from Add, cutting our TP by 9.4% to Rs725 (from Rs800). This is in view of the spate of top management resignations, including the MD & CEO, which should increase business/margin disruption including risk of another round of deposit run-down, impact on asset quality, middlemanagement attrition, and possibility of appointment of an RBI nominee on the Board as well as a PSU banker as MD & CEO (similar to Bandhan/RBL).
|
|
28 Mar 2025
|
IndusInd Bank
|
Ventura
|
858.85
|
|
649.85
(32.16%)
|
|
Not Rated
|
|
|
Strategic and Operational Headwinds in Focus
|
|
26 Mar 2025
|
IndusInd Bank
|
Geojit BNP Paribas
|
858.85
|
701.00
|
655.30
(31.06%)
|
Target met |
Hold
|
|
|
|
|
12 Mar 2025
|
IndusInd Bank
|
Sharekhan
|
858.85
|
750.00
|
684.70
(25.43%)
|
Target met |
Hold
|
|
|
IndusInd Bank reported discrepancies in its derivative portfolio pertaining to transactions done over the past 7-8 years. During the internal review of the trade book in derivative portfolio in October 2024, the bank found some discrepancies.
|
|
11 Mar 2025
|
IndusInd Bank
|
ICICI Securities Limited
|
858.85
|
850.00
|
901.00
(-4.68%)
|
Target met |
Sell
|
|
|
IndusInd Bank (IIB) has communicated a preliminary one-time hit of ~2.35% of net-worth on its derivative portfolio. We peg the pre-tax hit at ~INR 20bn–21bn.
|
|
11 Mar 2025
|
IndusInd Bank
|
BOB Capital Markets Ltd.
|
858.85
|
870.00
|
655.95
(30.93%)
|
Target met |
Hold
|
|
|
Discrepancy in derivative portfolio account to adversely impact net worth by 2.35%, indicates weak internal controls
|
|
11 Mar 2025
|
IndusInd Bank
|
Prabhudas Lilladhar
|
858.85
|
1000.00
|
655.95
(30.93%)
|
16.43 |
Hold
|
|
|
driven by uncertainties relating to earnings quality and future leadership. Woes This discrepancy spanned across a 5-7yr period till 31st Mar'24, however, due to an RBI directive, there are no irregularities w.e.f. 1st Apr'24. While an external review is underway to ascertain the exact impact, internal review suggests a...
|
|
10 Mar 2025
|
IndusInd Bank
|
Motilal Oswal
|
858.85
|
1100.00
|
900.50
(-4.63%)
|
28.08 |
Buy
|
|
|
The RBI has approved the reappointment of Mr. Sumant Kathpalia as MD & CEO of the bank for a one-year term, effective 24th Mar’25, following the conclusion of his current term.
|
|
09 Mar 2025
|
IndusInd Bank
|
ICICI Securities Limited
|
858.85
|
850.00
|
936.75
(-8.32%)
|
Target met |
Sell
|
|
|
As opposed to the three-year term requested by IndusInd Bank’s (IIB) board for its incumbent MD & CEO, Mr Sumant Kathpalia, RBI has approved a term renewal for only one year.
|
|
03 Feb 2025
|
IndusInd Bank
|
Sharekhan
|
858.85
|
1200.00
|
1012.70
(-15.19%)
|
39.72 |
Buy
|
|
|
IndusInd Bank (IIB) reported weak performance in Q3FY2025 across key metrics on expected lines. Net interest income (NII) at Rs. 5,228 crore (below estimates led by lower NIM and slower credit growth) was down 1% y-o-y/2% q-o-q. NIM fell by 15 bps q-o-q to 3.93%, given lower growth in the unsecured book, repricing of the corporate book, higher slippages, and increased cost of funds (9 bps q-o-q).
|
|
01 Feb 2025
|
IndusInd Bank
|
BOB Capital Markets Ltd.
|
858.85
|
1190.00
|
1009.40
(-14.91%)
|
38.56 |
Buy
|
|
|
Subdued quarter with moderate growth in advances and deposits, MFI book under stress
|
|
31 Jan 2025
|
IndusInd Bank
|
Motilal Oswal
|
858.85
|
1200.00
|
991.20
(-13.35%)
|
39.72 |
Buy
|
|
|
IndusInd Bank (IIB)’s PAT declined 39% YoY/rose 5% QoQ to ~INR14b (in line), as NII and NIM were broadly in line, while provisions continued to remain high.
|
|
14 Nov 2024
|
IndusInd Bank
|
Geojit BNP Paribas
|
858.85
|
1119.00
|
1017.15
(-15.56%)
|
30.29 |
Hold
|
|
|
|
|
08 Nov 2024
|
IndusInd Bank
|
ICICI Direct
|
858.85
|
1350.00
|
1053.80
(-18.50%)
|
57.19 |
Buy
|
|
|
|
|
25 Oct 2024
|
IndusInd Bank
|
IDBI Capital
|
858.85
|
1650.00
|
1041.60
(-17.55%)
|
92.12 |
Buy
|
|
|
|